1 month ago
New Alzheimer’s Blood Test Offers Hope
A new blood test called p-tau217 can help doctors detect Alzheimer’s disease earlier.
This test measures a protein in the blood that increases when abnormal changes linked to Alzheimer’s start in the brain.
It is less invasive than traditional methods like spinal fluid tests and can be done with a simple blood sample.
While the test is highly accurate, doctors say it should be used along with other tests like MRI scans and cognitive assessments.
The test is mainly for people with serious memory problems and not for healthy individuals just because they have a family history of Alzheimer’s.
Earlier detection can help with treatment planning and managing the disease better.
However, there are still challenges like making the test available and affordable for everyone.
The p-tau217 blood test detects a protein linked to Alzheimer’s disease.
It is less invasive and more accessible than traditional diagnostic methods.
The test is highly accurate but should be used alongside other diagnostic tools.
It is recommended for people with persistent memory problems or cognitive symptoms.
Earlier detection can improve treatment planning and management of the disease.
- Who
- People with persistent memory problems or cognitive symptoms
- What
- A blood test measuring p-tau217 protein for Alzheimer’s diagnosis
- Where
- Primarily in research settings and tertiary care centers
- When
- Currently available but not widely standardized
- Why
- To identify Alzheimer’s disease earlier and distinguish it from other causes of dementia
Proponents of the p-tau217 Test
Cautious Medical Professionals
Diagnostic Accuracy
Proponents of the p-tau217 Test
The p-tau217 test is highly accurate and aligns closely with amyloid PET scans and CSF analysis.
Cautious Medical Professionals
The test should not be used as a standalone diagnostic tool and must be supported by other assessments.
Invasiveness and Accessibility
Proponents of the p-tau217 Test
The blood test is less invasive and more accessible compared to traditional methods like lumbar punctures.
Cautious Medical Professionals
Traditional methods like MRI scans and cognitive assessments remain essential for a comprehensive diagnosis.
Early Detection and Treatment
Proponents of the p-tau217 Test
Earlier detection allows for better treatment planning and management of modifiable risk factors.
Cautious Medical Professionals
The test is not a cure and should be used in conjunction with other diagnostic tools for optimal outcomes.
Key facts
- Test Name
- p-tau217 blood test
- Detected Protein
- p-tau217
- Diagnostic Use
- Identifies Alzheimer’s disease and distinguishes it from other causes of dementia
- Accuracy
- Highly accurate, aligns with amyloid PET scans and CSF analysis
- Recommended For
- People with persistent memory problems or cognitive symptoms
- Current Limitations
- Standardization, validation in diverse populations, affordability, and access
Quotes
Dr. Sheetal Goyal
Consultant Neurologist, Wockhardt Hospitals, Mumbai Central
“"Earlier detection allows patients to begin treatment sooner, better manage modifiable risk factors, plan for future care, and, where appropriate, access disease‑modifying therapies."”
indianexpress.com
“"The p-tau217 blood test measures a protein that increases when the abnormal tau changes linked to Alzheimer’s disease start in the brain."”
indianexpress.com
Sources
Related news
OpenAI Rolls Out GPT-5.6-Cyber Cybersecurity Model After Astra AI Delay
Anthropic hires former California Supreme Court justice amid AI incidents
CERT-In Warning: Microsoft Teams, Office, Azure Face Hacking Risk
Microsoft Says False Defender Shutdown Alerts Are Windows Glitch
Hyderabad's Global Knowledge Hub Gains Support From World Universities
Study Links White Matter Health to Cognitive Resilience
Lifestyle Changes May Delay Alzheimer's Symptoms
